Abstract
Bouvardia ternifolia has been used medicinally to treat inflammation. In the present study, we investigate the anti-Alzheimer’s potential effect of the hydroalcoholic extract of B. ternifolia through evaluation of anti-inflammatory and antioxidant activities, quantification of the percentage inhibition of acetylcholinesterase activity, protection effect against β-amyloid fibrillar-induce neurotoxicity, and the identification of the main constituents. Our results show that B. ternifolia extract and ethyl acetate fraction induced anti-inflammatory effects by reducing inflammation by >70 %, while antioxidant test revealed significant IC50 values for flavonoid content fraction (30.67 ± 2.09 μg/ml) and ethyl acetate fraction (42.66 ± 0.93 μg/ml). The maximum inhibition of acetylcholinesterase was exhibited by scopoletin content fraction (38.43 ± 3.94 %), while ethyl acetate fraction exerted neuroprotective effect against β-amyloid peptide (83.97 ± 5.03 %). Phytochemical analysis, showed the presence of 3-O-quercetin glucopyranoside (415 mg/g), rutin (229.9 mg/g), ursolic and oleanolic acid (54 and 20.8 mg/g respectively), 3-O-quercetin rhamnopyranoside (12.8 mg/g), chlorogenic acid (9.5 mg/g), and scopoletin (1.38 mg/g). Our findings support the use of B. ternifolia since the extract induced significant neuroprotection against β-amyloid peptide, anti-inflammatory, antioxidant and anti-acetylcholinesterase effects that could be attributed to its contents of polyphenols, coumarins, and triterpenes, and encourage further studies for development of this extract as therapeutic agent in treatment of Alzheimer’s disease.
Similar content being viewed by others
References
Argueta-Villamar, A., L.M. Cano-Asseleih, and M.E. Rodarte. 1994. Atlas de las Plantas de la Medicina Tradicional Mexicana. Mexico D.F.: Instituto Nacional Indigenista.
Alfirevic, A., T. Mills, D. Carr, B.J. Barratt, A. Jawaid, J. Sherwood, J.C. Smith, J. Tugwood, R. Hartkoorn, A. Owen, K.B. Park, and M. Pirmohamed. 2007. Tacrine-induced liver damage: An analysis of 19 candidate genes. Pharmacogenetics and Genomics 17: 1091–1100.
Chang, T.N., J.S. Deng, Y.C. Chang, C.Y. Lee, and L. Jung-Chun. 2012. Ameliorative effects of scopoletin from Crossostephium chinensis against inflammation pain and its mechanisms in mice. Evidence-Based Complementary and Alternative Medicine 2012: 1–10.
Chen, Q.X., and I. Kubo. 2002. Kinetics of mushroom tyrosinase inhibition by quercetin. Journal of Agriculture and Food Chemistry 50: 4108–4112.
Dahlgren, K.N., A.M. Manelli, W.B. Stine Jr, L.K. Baker, G.A. Krafft, and M.J. LaDu. 2002. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. Journal of Biological Chemistry 277: 32046–32053.
De Young, L.M., J.B. Kheifets, S.J. Ballaron, and J.M. Young. 1989. Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents. Agents and Actions 26: 335–341.
Deharo, E., and H. Ginsburg. 2011. Analysis of additivity and synergism in the anti-plasmodial effect of purified compounds from plant extracts. Malaria Journal 10(Suppl 1): S5.
Du, W.Y., C. Chang, Y. Zhang, Y.Y. Liu, and K. Sun. 2013. High-dose chlorogenic acid induces inflammation reactions and oxidative stress injury in rats without implication of mast cell degranulation. Journal of Ethnopharmacology 147: 74–83.
Dunn, N.R., G.L. Pearce, and S.A. Shakir. 2000. Adverse effects associated with the use of donepezil in general practice in England. Journal of Psychopharmacology 14: 406–408.
Ellman, G.L., K.D. Courtney, B. Andres, and R.M. Featherstone Jr. 1961. New and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 7: 88–95.
Esterbauer, H., and K.H. Cheeseman. 1990. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods in Enzymology 186: 407–421.
Fernandez, S.P., C. Wasowski, A.C. Paladini, and M. Marder. 2005. Synergistic interaction between hesperidin, a natural flavonoid, and diazepam. European Journal of Pharmacology 512: 189–198.
Francis, P.T., A.M. Palmer, M. Snape, and G.K. Wilcock. 1999. The cholinergic hypothesis of Alzheimer’s disease: A review of progress. Journal of Neurology, Neurosurgery and Psychiatry 66: 137–147.
González, A., E. Gómez, A. Cortés-Lozada, S. Hernández, T. Ramirez-Apan, and A. Nieto-Camacho. 2009. Hepatocoordinate Tin(IV) compounds derived from pyridine Schiff bases: Synthesis, characterization, in vitro cytotoxicity, anti-inflammatory and antioxidant activity. Chemical & Pharmaceutical Bulletin 57: 5–15.
Hampel, H., D. Prvulovic, S. Teipel, F. Jessen, and C. Luckhaus. 2011. The future of Alzheimer’s disease: The next 10 years. Progress in Neurobiology 95: 718–728.
Heneka, M.T., and M.K. O’Banion. 2007. Inflammatory processes in Alzheimer’s disease. Journal of Neuroimmunology 184: 69–91.
Herrera-Ruiz, M., G. García-Morales, A. Zamilpa, M. González-Cortazar, J. Tortoriello, E. Ventura-Zapata, and E. Jiménez-Ferrer. 2012. Inhibition of acetylcholinesterase activity by hidroalcoholic extract and their fractions of Bouvardia ternifolia (Cav.) Schltdl (Rubiaceae). Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas 11: 526–541.
Jimenez-Ferrer, E., I. Reynosa-Zapata, Y. Perez-Torres, and J. Tortoriello. 2005. The secretagogue effect of the poison from Centruroides limpidus limpidus on the pancreas of mice and the antagonistic action of the Bouvardia ternifolia extract. Phytomedicine 12: 65–71.
Jolad, S.D., J.J. Hoffmann, S.J. Torrance, R.M. Wiedhopf, J.R. Cole, S.K. Arora, R.B. Bates, R.L. Gargiulo, and G.R. Kriek. 1977. Bouvardin and deoxybouvardin, antitumor cyclic hexapeptides from Bouvardia ternifolia (Rubiaceae). Journal of the American Chemical Society 99: 8040–8044.
Kim, H.J., S.I. Jang, Y.J. Kim, H.T. Chung, Y.G. Yun, T.H. Kang, O.S. Jeong, and Y.C. Kim. 2004. Scopoletin suppresses pro-inflammatory cytokines and PGE2 from LPS-stimulated cell line, RAW 264.7 cells. Fitoterapia 75: 261–266.
Kombal, R., and H. Glasl. 1995. Flavan-3-ols and flavonoids from Potentilla anserina. Planta Medica 61: 484–485.
Kurapati, K.R.V., V.S.R. Atluri, T. Samikkannu, and M.P.N. Nair. 2013. Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: Implications in HIV-associated neurocognitive disorders (HAND). PLoS One 8: e77624.
Kwon, S.H., H.K. Lee, J.A. Kim, S.I. Hong, H.C. Kim, T.H. Jo, Y.I. Park, C.K. Lee, Y.B. Kim, S.Y. Lee, and C.G. Jang. 2010. Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice. European Journal of Pharmacology 649: 210–217.
Lee, Y.J., S.B. Han, S.Y. Nam, K.W. Oh, and J.T. Hong. 2010. Inflammation and Alzheimer’s disease. Archives of Pharmacal Research 33: 1539–1556.
Lin, F.M., L.R. Chen, E.H. Lin, F.C. Ke, H.Y. Chen, M.J. Tsai, and P.W. Hsiao. 2007. Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells. Carcinogenesis 28: 2521–2529.
Liu, J. 1995. Pharmacology of oleanolic acid and ursolic acid. Journal of Ethnopharmacology 49: 57–68.
Materska, M. 2008. Quercetin and its derivatives: Chemical structure and bioactivity—a review. Polish Journal of Food and Nutrition Sciences 58: 407–413.
Morishita, H., and M. Ohnishi. 2001. Absorption, metabolism and biological activities of chlorogenic acids and related compounds. Studies in Natural Products Chemistry 25: 919–953.
Nagafuji, S., H. Okabe, H. Akahane, and F. Abe. 2004. Trypanocidal constituents in plants 4. Withanolides from the aerial parts of Physalis angulata. Biological and Pharmaceutical Bulletin 27: 193–197.
Ng, T.B., F. Liu, and Z.T. Wang. 2000. Antioxidative activity of natural products from plants. Life Sciences 66: 709–723.
Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 95: 351–358.
Pasinetti, G.M. 2012. Novel role of red wine-derived polyphenols in the prevention of Alzheimer’s disease dementia and brain pathology: Experimental approaches and clinical implications. Planta Medica 78: 1614–1619.
Patel, D., and T. Good. 2007. A rapid method to measure beta-amyloid induced neurotoxicity in vitro. Journal of Neuroscience Methods 161: 1–10.
Pu, F., K. Mishima, K. Irie, K. Motohashi, Y. Tanaka, K. Orito, T. Egawa, Y. Kitamura, N. Egashira, K. Iwasaki, and M. Fujiwara. 2007. Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. Journal Of Pharmacological Sciences 104: 329–334.
Razboršek, M.I., D.B. Vonĉina, V. Doleĉek, and E. Vonĉina. 2008. Determination of oleanolic, betulinic and ursolic acid in Lamiaceae and mass spectral fragmentation of their trimethylsilylated derivatives. Chromatographia 67: 433–440.
Recio, M.C., R.M. Giner, S. Manez, and J.L. Rios. 1994. Structural considerations on the iridoids as anti-inflammatory agents. Planta Medica 60: 232–234.
Rosoanaivo, P., C.W. Wright, M.I. Willcox, and B. Gilbert. 2011. Whole plant extracts versus single compounds for the treatment of malaria: Synergy and positive interactions. Malaria Journal 10(Suppl 1): S4.
Sari, A. 2010. Two new 3-benzylphthalides from Scorzonera veratrifolia Fenzl. Natural Product Research 24: 56–62.
Senol, F.S., K. Skalicka Wozniak, M.T.H. Khan, I. Erdogan Orhan, B. Sener, and K. Głowniak. 2011. An in vitro and in silico approach to cholinesterase inhibitory and antioxidant effects of the methanol extract, furanocoumarin fraction, and major coumarins of Angelica officinalis L. fruits. Phytochemistry Letters 4: 462–467.
Shan, J., J. Fu, Z. Zhao, X. Kong, and H. Huang. 2009. Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-kappaB and JNK/AP-1 activation. International Immunopharmacology 9: 1042–1048.
Tarozzi, A., F. Morroni, A. Merlicco, C. Bolondi, G. Teti, M. Falconi, G. Cantelli-Forti, and P. Hrelia. 2010. Neuroprotective effects of cyanidin 3-O-glucopyranoside on amyloid beta (25-35) oligomer-induced toxicity. Neuroscience Letters 473: 72–76.
Tobey, R.A., D.J. Orlicky, L.L. Deaven, L.B. Rall, and R.J. Kissane. 1978. Effects of Bouvardin (NSC 259968), a cyclic hexapeptide from Bouvardia ternifolia, on the progression capacity of cultured Chinese hamster. Cancer Research 38: 4415–4421.
Wagner, C., R. Fachinetto, C.L. Dalla Corte, V.B. Brito, D. Severo, G. de Oliveira Costa Dias, A.F. Morel, C.W. Nogueira, and J.B. Rocha. 2006. Quercitrin, a glycoside form of quercetin, prevents lipid peroxidation in vitro. Brain Research 1107: 192–198.
Wang, S.W., Y.J. Wang, Y.J. Su, W.W. Zhou, S.G. Yang, R. Zhang, M. Zhao, Y.N. Li, Z.P. Zhang, D.W. Zhan, and R.T. Liu. 2012. Rutin inhibits beta-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines. Neurotoxicology 33: 482–490.
Weiner, M.W., D.P. Veitch, P.S. Aisen, L.A. Beckett, N.J. Cairns, R.C. Green, D. Harvey, C.R. Jack, W. Jagust, E. Liu, J.C. Morris, R.C. Petersen, A.J. Saykin, M.E. Schmidt, L. Shaw, J.A. Siuciak, H. Soares, A.W. Toga, and J.Q. Trojanowski. 2012. The Alzheimer’s disease neuroimaging initiative: A review of papers published since its inception. Alzheimer’s & Dementia 8: S1–S68.
Wollen, K.A. 2010. Alzheimer’s disease: The pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Alternative Medicine Review 15: 223–244.
Yen, C.T., P.W. Hsieh, T.L. Hwang, Y.H. Lan, F.R. Chang, and Y.C. Wu. 2009. Flavonol glycosides from Muehlenbeckia platyclada and their anti-inflammatory activity. Chemical & Pharmaceutical Bulletin 57: 280–282.
Yoo, K.Y., and S.Y. Park. 2012. Terpenoids as potential anti-Alzheimer’s disease therapeutics. Molecules 17: 3524–3538.
Yoon, J.H., K. Youn, C.T. Ho, M.V. Karwe, W.S. Jeong, and M. Jun. 2014. p-Coumaric acid and ursolic acid from Corni fructus attenuated β-amyloid (25-35)-induced toxicity through regulation of the NF-κB signaling pathway in PC12 cells. Journal of Agriculture and Food Chemistry 62: 4911–4916.
Acknowledgments
This study was supported by grant R-2010-1701-57 (to A. A.-R.) from the FIS-Instituto Mexicano del Seguro Social, México. G. García-Morales is grateful for a doctoral fellowship from CONACyT (Exp. No. 212,779). The authors wish to thank Jonathan Orduño, Arturo Pérez (CIBIS-IMSS), and Antonio Nieto-Camacho (Instituto de Química-UNAM) for technical assistance.
Conflict of interest
The authors declare that there is no conflict of interests regarding the publication of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
García-Morales, G., Huerta-Reyes, M., González-Cortazar, M. et al. Anti-inflammatory, antioxidant and anti-acetylcholinesterase activities of Bouvardia ternifolia: potential implications in Alzheimer’s disease. Arch. Pharm. Res. 38, 1369–1379 (2015). https://doi.org/10.1007/s12272-015-0587-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-015-0587-6